Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 129.19B | 129.02B | 115.43B | 97.84B | 96.22B | 103.97B |
Gross Profit | 26.00B | 25.21B | 24.08B | 18.20B | 23.62B | 22.87B |
EBITDA | 18.40B | 17.20B | 16.75B | 11.35B | 16.10B | 15.21B |
Net Income | 10.84B | 10.05B | 9.78B | 5.93B | 9.26B | 8.83B |
Balance Sheet | ||||||
Total Assets | 159.11B | 159.43B | 161.90B | 142.43B | 136.98B | 132.45B |
Cash, Cash Equivalents and Short-Term Investments | 40.52B | 45.58B | 47.20B | 42.95B | 42.08B | 35.55B |
Total Debt | 3.90B | 3.70B | 4.60B | 5.70B | 2.53B | 3.64B |
Total Liabilities | 53.30B | 51.49B | 60.88B | 52.25B | 51.56B | 55.51B |
Stockholders Equity | 105.80B | 107.92B | 101.02B | 90.17B | 85.42B | 76.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.29B | 6.87B | -1.19B | 8.82B | 9.80B |
Operating Cash Flow | 0.00 | 9.07B | 10.43B | 4.85B | 12.80B | 14.32B |
Investing Cash Flow | 0.00 | -6.62B | -3.45B | -5.33B | -3.56B | -2.60B |
Financing Cash Flow | 0.00 | -3.81B | -3.04B | 1.22B | -3.10B | -3.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥102.71B | 7.59 | 3.44% | 7.65% | 8.12% | ||
77 Outperform | ¥96.47B | 11.44 | 3.05% | -0.98% | -18.48% | ||
74 Outperform | ¥130.67B | 22.96 | 3.59% | >-0.01% | -26.82% | ||
74 Outperform | ¥105.66B | 14.05 | 2.07% | 15.99% | 32.43% | ||
73 Outperform | ¥105.73B | 10.91 | 2.46% | 12.25% | 32.16% | ||
69 Neutral | ¥94.35B | 9.39 | 2.64% | 11.77% | 2.77% | ||
63 Neutral | $10.70B | 15.26 | 7.37% | 2.02% | 2.87% | -14.59% |